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Abstract: With obesity being a leading cause of preventable death, it is vital to understand how best to
identify individuals with greater risk of metabolic disease, especially those with high visceral adipose
tissue (VAT). This study aimed to determine whether three commonly used waist circumference (WC)
measurement sites could provide accurate estimations of VAT, as determined by magnetic resonance
imaging (MRI), which is a gold standard for measuring VAT, in postmenopausal women with obesity.
VAT volume was measured by MRI of the total abdomen in 97 women aged 57.7 ± 0.4 years (mean
± SEM), mean body mass index 34.5 ± 0.2 kg/m2. WC was measured at the midpoint between
the lowest rib and the iliac crest (WCmid), the narrowest point of the torso (WCnarrow), and at the
level of the umbilicus (WCumbilicus). WC differed significantly according to measurement site, with
WCnarrow (102.1± 0.7 cm) < WCmid (108.3± 0.7 cm) < WCumbilicus (115.7± 0.8 cm) (p < 0.001). WCmid,
WCnarrow and WCumbilicus were all significantly correlated with VAT, as measured by MRI (r = 0.581,
0.563 and 0.390, respectively; p < 0.001 for all), but the relationships between WCmid or WCnarrow
and VAT determined by MRI were stronger than for WCumbilicus. Measurement of either WCmid or
WCnarrow provides valid estimates of VAT in postmenopausal women with obesity, with WCnarrow
being favoured in light of its greater ease and speed of measurement in this population.
Keywords: waist circumference; magnetic resonance imaging; visceral adipose tissue; obesity
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1. Introduction
Obesity, which can be defined as an excess of body fat, is an ever-growing public health crisis related to
the development of many disturbances, including type 2 diabetes and cardiovascular disease [1,2]. Body fat
is distributed in two main compartments with different metabolic characteristics: subcutaneous adipose
tissue (SAT) and visceral adipose tissue (VAT). However, the metabolic risks associated with obesity, such
as impaired glucose and lipid metabolism, diabetes, insulin resistance [3–5], hypertension [6] and metabolic
syndrome [7], have been attributed to increases in VAT [8].
An accurate measure of VAT requires the use of gold-standard imaging techniques, such as
computed tomography (CT) or magnetic resonance imaging (MRI) [9]. However, while MRI, avoids
the radiation exposure encountered with CT, both CT and MRI are relatively inaccessible, expensive,
and image analysis is labour intensive [10]. Dual-energy X-ray absorptiometry (DXA) is an alternative
method for estimating VAT [11] that has been shown to correlate strongly with VAT measured
using CT [12–16] and MRI [17,18]. DXA delivers a minimal radiation dose and is less costly and
time-consuming than CT or MRI for measuring VAT [19]. However, DXA too requires expensive
equipment and trained technicians [19].
A simple index of VAT is waist circumference (WC), which provides a recognised estimate
of abdominal adiposity and metabolic risk [20]. There are different WC measurement sites that
are routinely used [21]. For example, a literature review identified 14 different descriptions
of the site for WC measurements [22]. However, there is no consensus regarding the optimal
WC measurement site [23]. The World Health Organisation recommends measuring WC at the
midpoint between the bony landmarks of the lowest rib and the top of the iliac crest (WCmid) [24].
The Anthropometric Standardization Reference Manual (developed in 1985 by experts attending the
Anthropometric Standardization Conference) recommends measuring WC at the narrowest point of
the torso (WCnarrow) [25]. In contrast, some research studies have measured WC at the level of the
umbilicus (WCumbilicus) [26,27], or have failed to describe the WC measurement site used at all [28,29].
A systematic review looking at 120 studies of WC measurement sites and morbidity or mortality
found that most WC measurements were performed at WCmid (30%), WCnarrow (27%) or WCumbilicus
(29%) [26]. Further, in the few studies that have investigated the relationship between VAT (using
the gold standard techniques of CT and MRI) and WC, they did so only in zero [30], one [31–33] or
two [34] of the three common WC measurement sites.
To identify those with greater levels of VAT and therefore, greater risk of metabolic disease,
especially in higher risk populations, such as older adults or those with obesity, we aimed to determine
which of the three common measures of WC (WCmid, WCnarrow and WCumbilicus) is the better predictor
of VAT, as determined by the gold standard method of MRI, specifically in postmenopausal women
with obesity.
2. Materials and Methods
2.1. Ethics Statement and Participants
The study was approved by the Sydney Local Health District Ethics Committee (Royal Prince
Alfred Hospital Zone) and registered with the Australia and New Zealand Clinical Trials registry
(number 12612000651886). All participants provided informed, written consent prior to participation.
Ninety-seven women, aged 57.7 ± 0.4 years (mean ± SEM), with a mean body mass index (BMI)
of 34.4 ± 0.3 kg/m2 participated in this study. Participants were at least five years postmenopausal at
the time of recruitment, and were predominately Caucasian (n = 92). Participants were recruited as
part of a broader study: the randomised controlled TEMPO Diet Trial (Type of Energy Manipulation
for Promoting optimum metabolic health and body composition in Obesity). All participants were
required to be weight stable (±2 kg) for ≥6 months, and sedentary (defined as <3 h of structured
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physical activity per week). Exclusion criteria were not being ambulatory, or having osteoporosis,
hyperthyroidism or hypothyroidism, diabetes mellitus, any loose metal in the body (e.g., pacemaker
or bullet) that is contraindicated for MRI for safety reasons, or which may result in artefacts in medical
imaging, tobacco use, alcohol or drug dependency.
2.2. Measurements
2.2.1. Anthropometry
Body weight (Tanita BWB-800 digital scale, Wedderburn Pty. Ltd., Sydney, Australia) and standing
height (Harpenden Stadiometer, Holtain Ltd., Crymych, UK) were both measured twice to the nearest
0.1 kg and 0.1 cm, respectively. If the difference between the measurements was >0.5 kg for body
weight or >0.5 cm for standing height, a third measurement was taken. The average of the two
measurements (or the average of the two closest measurements if a third measurement was taken) was
recorded as the result. Participants were dressed in leggings and a sports bra and were not wearing
shoes during measurement.
2.2.2. MRI
Abdominal fat volumes (i.e., VAT) were measured by MRI, with participants lying in a supine
position in a hospital gown, having removed any metal accessories. Axial T1-weighted fast field echo
images were acquired with a 3.0T MRI scanner (the Discovery MR750 3.0T model from GE Healthcare,
Milwaukee, WI, USA), from diaphragm to pelvis (repetition time = 3.8 ms, echo time = 2.1 ms, flip
angle = 12◦), with a slice thickness of 10 mm and an inter-slice gap (i.e., the distance between the
surfaces of adjacent slices) of 10 mm. Images were acquired during suspended end-expiration, with a
breath-hold duration of approximately 15–18 s per acquisition. Following the scan, all image slices
from the base of the lungs to the pelvic floor were segmented manually. VAT was quantified using
the Region Growing mode of the analysis software (SliceOMatic Version 5.0 rev-6b, Tomovision Inc.,
Montreal, QC, Canada), with thresholds adjusted manually, as required. The software automatically
calculated the surface area of each slice by multiplying the number of pixels tagged by the surface area
of one pixel. The inter-slice volume (i.e., the volume of the inter-slice gap) was extrapolated using a
cone formula that considered the surface area of the superior and inferior surfaces of the inter-slice
gap, as well as the thickness of the inter-slice gap. The total volume of each of the inter-slice gaps was
then added to the total volume of each of the slices (surface area × slice thickness) to calculate the total
abdominal volumes of VAT. All analyses were conducted by the same researcher (ALWT).
2.2.3. WC
WC was measured to the nearest 0.1 cm, directly on skin, using a narrow, flexible and inelastic
steel tape (Lufkin W606PM, Apex Tool Group, North Carolina, USA). Participants were dressed in
leggings and a sports bra. WC was measured at the three most commonly used sites worldwide [26];
WCmid, WCnarrow and WCumbilicus. Participants were asked to breathe normally and to stand with their
weight evenly distributed and their arms crossed over their shoulders during measurements. At each
measurement site, two measurements were taken, and if the difference between the measurements
was >1 cm, a third measurement was taken. The average of each of the two measurements at each site
(or the average of the two closest measurements if a third measurement was taken) was recorded as
the result. Measurements were taken by the same two researchers (SM and HAF) throughout the study.
The inter-observer coefficient of variation (CV) in a subset of five participants was 1.44% for WCmid,
0.66% for WCnarrow, and 0.69% for WCumbilicus. The intra-observer CV for the two measurements on
all 97 participants was 0.27% for WCmid, 0.32% for WCnarrow and 0.23% for WCumbilicus.
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2.3. Statistical Analysis
All data are presented as means ± standard error of the mean (SEM), unless otherwise stated.
A Shapiro–Wilk test of normality demonstrated the normal distribution of all data used in this study.
Comparisons between the three different WC measurement sites were performed using one-way
repeated measures ANOVA plus a post hoc test for multiple comparisons. Pearson correlations were
used to assess the relationships between VAT volume and different WC measurement sites, or BMI.
A Fisher’s z-transformation was used to determine if the correlation coefficients between each of
the relationships were significantly different from each other. Statistical significance was accepted
as p < 0.05. Statistical analyses were performed using SPSS Version 24 (IBM SPSS Statistics, IBM
Corporation, New York, NY, USA).
3. Results
Descriptive statistics for the participants in this study are presented in Table 1.
Table 1. Clinical and anthropometric characteristics of participants.
Age (years) 57.7 ± 0.4 (45–65)
Weight (kg) 91.1 ± 0.9 (76.6–116.4)
BMI (kg/m2) 34.5 ± 0.2 (29.6–40.1)
Waist circumferences (cm)
WCmid 108.3 ± 0.7 (93.8–125.8)
WCnarrow 102.1 ± 0.7 (85.3–120.8)
WCumbilicus 115.7 ± 0.8 (97.2–139.3)
VAT (cm3) 5,430 ± 200 (1510–10,840)
Data are presented as means ± SEM (range) of 97 postmenopausal women. BMI, body mass index; WCmid,
waist circumference measured at the midpoint; WCnarrow, WC measured at the narrowest point; WCumbilicus, WC
measured at the umbilicus; VAT, visceral adipose tissue volume (measured by magnetic resonance imaging).
The three different WC measurement sites produced significantly different results, with WCnarrow
< WCmid < WCumbilicus (Table 1, Figure 1). The greatest differences were observed between WCnarrow
and WCumbilicus (13.5 ± 0.6 cm, p < 0.05), then between WCmid and WCumbilicus (7.1 ± 0.6 cm, p < 0.05),
with the smallest difference being between WCnarrow and WCmid (6.3 ± 0.3 cm, p < 0.05).
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Figure 1. Waist circumference (WC) measurement at different sites. WC at the midpoint (WCmid),
narrowest point (WCnarrow) and umbilicus (WCumbilicus) for each individual participant (A); and as
means ± SEM (B), in postmenopausal women with obesity (n = 97). * p < 0.05 versus WCmid, # p < 0.05
versus WCumbilicus.
Despite the narrow BMI range of participants in this study (Table 1), in keeping with the selection
criteria, there was significant variation in WC (Table 1, Figure 1) and VAT volumes (Table 1, Figure 2)
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across the cohort. These wide ranges of WC and VAT values are helpful for the current study, in order
to demonstrate the relative utility of different WC measurement indexes.
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Figure 2. Visceral adipose tissue volume (VAT), as determined by magnetic resonance imaging for each
of the postmenopausal women with obesity in this study (n = 97).
The three different waist circumference measures, I, w re significantly correlated with
VAT, as determined by MRI (Figure 3). WCmid and WCnarrow were both moderate correlates of VAT,
while WCumbilicus was a weak, and BMI a very weak, correlate of VAT (as shown by the correlation
coefficients (r) and 95% confidence intervals in Figure 3).
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Figure 3. Visceral adipose tissue volume (VAT), measured by magnetic resonance imaging, versus waist
circumference measured at the midpoint (WCmid, A); narrowest point (WCnarrow, B) and umbilicus
(WCumbilicus, C); as well as body mass index (BMI, D), in postmenopausal women with obesity (n = 97).
Data on each pan l represent co r la ion coeffici nts (r) as well as their 95% confid nce int vals [lower
limit, upper limit], and corresponding p values.
There was no significant difference between the correlations of VAT–WCmid and VAT–WCnarrow
(z = 0.18, p = 0.86). The difference in correlations between VAT–WCmid and VAT–WCumbilicus
approached, but did not reach statistical significance (z = 1.73, p = 0.08), as did the correlations
between VAT–WCnarrow and VAT–WCumbilicus (z = 1.55, p = 0.12). In contrast, there was a significant
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difference between the correlations of VAT–BMI and VAT–WCmid (z = 2.35, p = 0.02) and VAT–BMI
and VAT–WCnarrow (z = 2.17, p = 0.03), but there was no significant difference in correlations between
VAT–BMI and VAT–WCumbilicus (z = 0.63, p = 0.53). In addition, when comparing each of the three
different WC measurement sites against one another, there was a strong correlation between WCmid
and WCnarrow (r = 0.91), which was significantly stronger than either of the correlations between
WCmid and WCumbilicus (r = 0.715), or WCnarrow and WCumbilicus (r = 0.702). This data, combined
with the correlations between VAT and different WC measurement sites, shows that the most useful
anthropometric indices of VAT volume are WCmid or WCnarrow.
4. Discussion
Our study investigated the correlation between VAT, as quantified by the gold standard method
of MRI, and all three of the most common WC measurement sites [26], namely WCmid, WCnarrow and
WCumbilicus. Our results indicate that WCmid and WCnarrow are the most appropriate WC measurement
sites for the estimation of VAT by MRI in postmenopausal women with obesity. Additionally, there
was no significant difference in the correlations between WCmid and WCnarrow with respect to their
correlations with VAT, indicating that both are very similar measurement sites, while WCnarrow is
easier and faster to measure than WCmid, as explained below.
While previous studies have investigated the relationship between VAT (determined by MRI
or CT) and WC, they only investigated zero [30], one [31–33] or two [34] of the three common
WC measurement sites. In the studies measuring only one WC site, they found WCmid [31],
WCnarrow [32,33], or WC measured at the halfway point between the L4 and L5 vertebrae [30], were
all associated with VAT. The study that looked at two of the three common WC measurement sites
(WCnarrow and WCumbilicus)—in an overweight to mildly obese population (average BMI 30.2 kg/m2,
range 25–35 kg/m2)—found that VAT area measured by CT correlated slightly more strongly with
WCnarrow (r = 0.63) than with WCumbilicus (r = 0.57) [34]. The current study extends knowledge from
this existent literature by directly comparing all three of the common WC measurement sites in
the same study, thereby allowing for selection of the most appropriate WC measurement site(s) in
postmenopausal women with obesity (WCmid or WCnarrow).
When considering the practicality of measuring WCmid or WCnarrow, WCnarrow is advantageous.
This is because when measuring WCmid, the observer needs to identify and mark two anatomical
landmarks (the bottom of the lowest rib and the top of the iliac crest), and then mark the midpoint
between these two landmarks before WC can be measured. In contrast, when measuring WCnarrow,
the observer can estimate the narrowest point of the torso by simply viewing the torso from the
back prior to measuring WC. As such, measuring WCnarrow is less time consuming than WCmid.
While some studies emphasise the need for bony landmarks to guide WC measurement [23], this can
be problematic. The identification of both the rib and the iliac crest for the measurement of WCmid
can be difficult in people with increased adiposity. To identify these two landmarks, the observer may
need to palpate the abdomen thoroughly, which can be intrusive and embarrassing for the subject [35].
In addition, at higher levels of adiposity, these landmarks might not be able to be located precisely,
which would make the measurement imprecise, because inaccurate localization of the border of either
the rib or the iliac crest can have a significant effect on the WC measured, thus leaving more room for
error [22]. In summary, WCnarrow is not only a good estimate of VAT in postmenopausal women with
obesity, but is also quicker and easier to measure than WCmid and offers the advantage of avoiding
the less practical procedure and potential imprecision of landmark identification. However, it should
be noted that these results are valid for an environment where highly trained researchers take the
measures, which may not apply to clinical practice.
This study showed that although WCumbilicus was significantly correlated with VAT, as had also
been shown in a previous study [34], it further showed that WCumbilicus was of limited value in
estimating VAT in postmenopausal women with obesity, when compared to WCmid or WCnarrow.
This may be related to the relatively low position of this the umbilicus site in the abdomen. A study in
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overweight or obese participants found that the correlation between VAT area, measured by single-slice
MRI, and VAT volume, measured by multi-slice MRI, was strongest higher in the abdomen compared to
lower [36]. These findings suggest that WC measured in the upper abdomen may correlate more closely
with VAT than WC measured in the lower abdomen. This can potentially explain the differences in the
correlations between VAT and different measurement sites, and supports our findings where WCmid
and WCnarrow—which are higher in the abdomen than WCumbilicus—are more strongly correlated with
VAT than WCumbilicus. In addition, although measuring WCumbilicus is the least time-consuming of all
three methods, a limitation in the use of WCumbilicus is the variability in its position, as the umbilicus is
a soft tissue landmark [37]. A study looking at umbilical position and BMI in males and females found
that the median position of the umbilicus was 0.88 cm, 1.20 cm, and 3.50 cm below the middle of the
torso in people who had a BMI in the normal, overweight, or obese range, respectively [38]. While this
change in the position of the umbilicus could indicate important VAT changes, the panniculus (the so
called ‘apron of fat’ upon which the umbilicus sits) consists of subcutaneous fat, and therefore a drop
in umbilical position is more likely to indicate subcutaneous fat accumulation than any change in
VAT [39]. Therefore, one might expect WCumbilicus to be a poorer correlate of VAT, especially in people
with obesity, due to its varying position on the torso.
In this study we also looked at the correlation between VAT (as determined by MRI) and BMI
in our 97 participants, and found that the correlation was very weak—significantly weaker than
the relationship between WCmid or WCnarrow and VAT. This finding underscores the strength and
specificity of the correlation between WCmid or WCnarrow and VAT. This finding is in contrast to
large-scale population-based studies, including ~3,000–4,500 people, where BMI was significantly
correlated with VAT, as measured by CT [4,40]. This highlights that although BMI may be an
appropriate estimator of metabolic risk in large-scale population studies, it is not appropriate for
evaluation of metabolic risk in smaller studies or in individuals [41].
Another finding from this study is that the site of WC measurement significantly influences
the magnitude of the measurement, with WCnarrow < WCmid < WCumbilicus in our population
of postmenopausal women with obesity. This finding is consistent with previous investigations
suggesting that WC measurements made using different protocols are not all comparable [22,34,42].
For instance, in a study of WC measurements taken at four sites in 57 women, there were significant
differences between all measurement sites (WCnarrow < WC immediately below the lowest rib <
WCmid < WC immediately above the iliac crest; p < 0.05 for all comparisons) [22]. The current study
advances on existing findings by showing—within the same study—that even the three commonly used
WC measurement sites are significantly different from each other, even in a relatively homogenous
population of postmenopausal women with obesity. This calls into question the practice of not
reporting the specific site at which WC was measured, as in some publications [28,29].
This study has several limitations and strengths. Selection criteria for the present study were
narrow, and while this limits the ability to generalise the results to other population groups, it also
strengthens the findings by making them specific to a high-risk population of postmenopausal women
with obesity—a population where WC measurement site differences were relatively unknown. Another
limitation of our study is that the WC measures were not investigated under conditions of weight
change. In addition, a potential source of measurement error for all WC sites is incorrectly positioning
the tape measure on the subject’s body, however, this was minimised in the current study with the use
of only two researchers assessing WC. In addition, the heavy-duty tape measure used in our study
was flexible, inelastic, and firm, making it easy to place around the trunk region of the body in the
same plane. Another strength of our study was that data variability was reduced by the consistent
analysis of MRI scans by one researcher for the whole study.
In conclusion, measurement of WCmid or WCnarrow are accurate, practical and cost-effective
means of estimating VAT in postmenopausal women with obesity, with WCnarrow offering several
advantages for ease, speed and precision of measurement over WCmid.
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